Updates in the Use of Biosimilars in the Management of Retinal Eye Disorders - Episode 2
Carl D. Regillo, MD, and Jennifer I. Lim, MD, review the regulatory oversight process regarding biosimilars after they have entered the market.
Innovent announces first patient dosed in Phase 1 study of IBI324 in patients with diabetic macular edema
Rachitskaya: Archway found incidence of retinal fluid at Week 96 was generally comparable across treatment arms
Study: Changes in the retina may be linked to parts of the brain of healthy individuals at risk of Alzheimer’s